Latest Period
Q2 2026
Security Snapshot
PROTAGONIST THERAPEUTICS INC - COM Institutional Ownership
CUSIP: 74366E106
13F Institutional Holders and Ownership History from Q3 2018 to Q2 2026
Institutions Reporting
2
Shares (Excl. Options)
70,582
Price
$122.11
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 70,582
- Total 13F value
- $8,590,205
- Portfolio coverage rank
- 0%
- Share change
- +65,546
- Value change
- +$7,972,887
- Number of holders
- 2
- SEC-reported price per share
- $122.11
Latest holder snapshot
4 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- 74366E106 - PROTAGONIST THERAPEUTICS INC - COM is tracked under CUSIP 74366E106.
- 2 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 1 to 2 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $530,799 to $8,590,205.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 2 institutions filings for Q2 2026.
Security key
74366E106
Latest holder period
Q2 2026
13F holders
2
13D/G owners
0
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74366E106:
As of 30 Jun 2026, 2 institutional investors reported holding 70,582 shares of PROTAGONIST THERAPEUTICS INC - COM.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 70,582 | $8,590,205 | +$7,972,887 | $122.11 | 2 |
| 2026 Q1 | 5,036 | $530,799 | -$44,690 | $105.40 | 1 |
| 2025 Q4 | 5,460 | $476,880 | +$476,880 | $87.34 | 1 |
| 2022 Q4 | 0 | $0 | -$1,031,000 | $122.11 | 0 |
| 2022 Q3 | 122,271 | $1,031,000 | +$1,031,000 | $8.43 | 1 |
| 2021 Q4 | 0 | $0 | -$18,000 | $122.11 | 0 |
| 2021 Q3 | 1,000 | $18,000 | $18.00 | 1 | |
| 2021 Q2 | 1,000 | $45,000 | $45.00 | 1 | |
| 2018 Q4 | 0 | $0 | -$117,000 | $122.11 | 0 |
| 2018 Q3 | 11,400 | $117,000 | +$117,000 | $10.26 | 1 |